N-Myc-mediated epigenetic reprogramming in advanced prostate cancer: personalized medicine and quality of biological samples

Saverio Bettuzzi^{1

2}

Affiliations

¹ Department of Medicine and Surgery (DIMEC), University of Parma, Parma, Italy.
² INBB, National Institute of Biostructure and Biosystems, Rome, Italy.

Editorial

Saverio Bettuzzi. Transl Cancer Res. 2019 Dec.

. 2019 Dec;8(Suppl 6):S639-S641.

doi: 10.21037/tcr.2019.10.07.

Saverio Bettuzzi^{1

2}

¹ Department of Medicine and Surgery (DIMEC), University of Parma, Parma, Italy.
² INBB, National Institute of Biostructure and Biosystems, Rome, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author is co-inventor of the Twin Sample needle for prostate biopsies mentioned in the manuscript.

N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
Berger A, Brady NJ, Bareja R, Robinson B, Conteduca V, Augello MA, Puca L, Ahmed A, Dardenne E, Lu X, Hwang I, Bagadion AM, Sboner A, Elemento O, Paik J, Yu J, Barbieri CE, Dephoure N, Beltran H, Rickman DS. Berger A, et al. J Clin Invest. 2019 Jul 1;129(9):3924-3940. doi: 10.1172/JCI127961. J Clin Invest. 2019. PMID: 31260412 Free PMC article.

1. Rider JR, Sandin F, Andren O, et al. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study. Eur Urol 2013;63:88-96. 10.1016/j.eururo.2012.08.001 - DOI - PubMed
1. Van Emelrijck M, Folkvaljon Y, Adolfsson J, et al. Causes of death in men with localized prostate cancer: a nationwide. population-based study. BJU Int 2016;117:507-14. 10.1111/bju.13059 - DOI - PMC - PubMed
1. Berger A, Brady NJ, Bareja R, et al. N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer. J Clin Invest 2019;130;3924-40. 10.1172/JCI127961 - DOI - PMC - PubMed
1. Lee JK, Phillips JW, Smith BA, et al. N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. Cancer Cell 2016;29:536-47. 10.1016/j.ccell.2016.03.001 - DOI - PMC - PubMed
1. Aggarwal R, Zhang T, Small EJ, et al. Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes. J Natl Compr Canc Netw 2014;12:719-26. 10.6004/jnccn.2014.0073 - DOI - PubMed